Nanosphere Inc., a Northbrook, Ill.-based molecular diagnostics company with a nanotech-based platform to enable earlier disease detection and treatment, raised $98 million in its IPO. The company priced seven million common shares at $14 per share ($14-$16 range), for an initial market cap of approximately $295 million. It will trade on the Nasdaq under ticker symbol NSPH, while Lehman Brothers served as lead underwriter.
Nanosphere had raised around $80 million in VC funding since 2000, including a Series D round in 2006 at a post-money valuation of just under $120 million. Shareholders include Brookside Capital Partners, Lurie Investments, Bain Capital Ventures and Allen & Company. www.nanosphere.us